Skip to main content
Erschienen in: Supportive Care in Cancer 1/2022

10.07.2021 | Original Article

The untold story of late effects: a qualitative analysis of breast cancer survivors’ emotional responses to late effects

verfasst von: Jodie Rosenberg, Phyllis N. Butow, Joanne M. Shaw

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast cancer survivors are at increased risk of adverse outcomes, called late effects, years after the completion of active treatment. Late effects can significantly impair physical functioning. The current study aimed to explore breast cancer survivors’ experiences of late effects, their emotional responses to existing or potential late effects and their perceived impact.

Methods

A total of 36 women treated for breast cancer in the last 10 years participated in semi-structured telephone interviews. Participant views were sought with respect to knowledge, experience, and perceived longer-term risk. A thematic analysis was conducted.

Results

Four themes emerged from the data: (1) late effects awareness, (2) framing and coping, (3) uncertainty and (4) management. There was a range of emotional responses to late effects; however, many participants reported being unaware of their risk of late effects. Participants conceptualised late effects as any long-term effect of treatment regardless of the time of onset. Women reported living with constant uncertainty and feared cancer recurrence. Many were focused on managing long-term treatment side effects, rather than late effects.

Conclusion

Many women undergo treatment and remain unaware of associated late effect risks. National guidelines recommend patients be informed about late effects; however, the results of this study suggest a gap between policy and practice. Evidence-based interventions are needed to equip women with strategies to physically and emotionally manage late effects.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Vivek R (2018) Tactics of breast cancer therapeutics and future outlooks. J Cancer Biol Res 6(2):1120 Vivek R (2018) Tactics of breast cancer therapeutics and future outlooks. J Cancer Biol Res 6(2):1120
3.
Zurück zum Zitat Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L (2018) Management of side effects during and post-treatment in breast cancer survivors. Breast J 24(2):167–175PubMedCrossRef Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L (2018) Management of side effects during and post-treatment in breast cancer survivors. Breast J 24(2):167–175PubMedCrossRef
4.
Zurück zum Zitat Mandelblatt JS, Zhai W, Ahn J, Small BJ, Ahles TA, Carroll JE, …, Cohen HJ (2020) Symptom burden among older breast cancer survivors: the thinking and living with cancer (TLC) study. Cancer 126(6):1183–1192 Mandelblatt JS, Zhai W, Ahn J, Small BJ, Ahles TA, Carroll JE, …, Cohen HJ (2020) Symptom burden among older breast cancer survivors: the thinking and living with cancer (TLC) study. Cancer 126(6):1183–1192
5.
Zurück zum Zitat Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén PO (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer Clin Oncol 27(9):1075–1081CrossRef Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén PO (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer Clin Oncol 27(9):1075–1081CrossRef
6.
Zurück zum Zitat Alvarado I, Wisotzky E, Cheville AL (2019) Differences in perceived risk at which clinician and patient stakeholders initiate activities to prevent late effects among breast cancer survivors. Arch Rehabil Res Clin Transl 1(1–2):100006PubMedPubMedCentral Alvarado I, Wisotzky E, Cheville AL (2019) Differences in perceived risk at which clinician and patient stakeholders initiate activities to prevent late effects among breast cancer survivors. Arch Rehabil Res Clin Transl 1(1–2):100006PubMedPubMedCentral
7.
Zurück zum Zitat Aziz NA (2007) Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 46:417–432PubMedCrossRef Aziz NA (2007) Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 46:417–432PubMedCrossRef
8.
Zurück zum Zitat Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD (2016) Cardiovascular disease mortality among breast cancer survivors. Epidemiology 27(1):6–13PubMedPubMedCentralCrossRef Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD (2016) Cardiovascular disease mortality among breast cancer survivors. Epidemiology 27(1):6–13PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Aznar MC, Duane FK, Darby SC, Wang Z, Taylor CW (2018) Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010–2015. Radiother Oncol 126(1):148–154PubMedPubMedCentralCrossRef Aznar MC, Duane FK, Darby SC, Wang Z, Taylor CW (2018) Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010–2015. Radiother Oncol 126(1):148–154PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Wang R, Yin Z, Liu L, Gao W, Li W, Shu Y, Xu J (2018) Second primary lung cancer after breast cancer: a population-based study of 6,269 women. Front Oncol 8:427PubMedPubMedCentralCrossRef Wang R, Yin Z, Liu L, Gao W, Li W, Shu Y, Xu J (2018) Second primary lung cancer after breast cancer: a population-based study of 6,269 women. Front Oncol 8:427PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Beadle G, Baade P, Fritschi L (2009) Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers. Ann Oncol 20(1):103–109PubMedCrossRef Beadle G, Baade P, Fritschi L (2009) Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers. Ann Oncol 20(1):103–109PubMedCrossRef
12.
Zurück zum Zitat Sánchez L, Lana A, Hidalgo A et al (2008) Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev 17(5):406–413PubMedCrossRef Sánchez L, Lana A, Hidalgo A et al (2008) Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev 17(5):406–413PubMedCrossRef
13.
Zurück zum Zitat Shah C, Vicini FA (2011) Breast cancer related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 81:907–914PubMedCrossRef Shah C, Vicini FA (2011) Breast cancer related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 81:907–914PubMedCrossRef
14.
Zurück zum Zitat Bodai B, Tuso P (2015) Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J 19(2):48–79PubMedPubMedCentralCrossRef Bodai B, Tuso P (2015) Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J 19(2):48–79PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Lee TS, Kilbreath SL, Refshuage KM, Herbert RD, Beith JM (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110:19–37PubMedCrossRef Lee TS, Kilbreath SL, Refshuage KM, Herbert RD, Beith JM (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110:19–37PubMedCrossRef
16.
Zurück zum Zitat Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333PubMedPubMedCentralCrossRef Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Tabrizi FM, Alizadeh S (2017) Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica 12(2):106–111PubMedPubMedCentral Tabrizi FM, Alizadeh S (2017) Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica 12(2):106–111PubMedPubMedCentral
18.
Zurück zum Zitat Selamat MH, Loh SY, Mackenzie L, Vardy J (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One 9(9):e108002PubMedPubMedCentralCrossRef Selamat MH, Loh SY, Mackenzie L, Vardy J (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One 9(9):e108002PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Jacobs LA, Shulman LN (2017) Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol 18(1):e19–e29PubMedCrossRef Jacobs LA, Shulman LN (2017) Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol 18(1):e19–e29PubMedCrossRef
20.
Zurück zum Zitat Ewertz M, Jensen AB (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187–193PubMedCrossRef Ewertz M, Jensen AB (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187–193PubMedCrossRef
21.
Zurück zum Zitat Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41(17):2613–2619PubMedCrossRef Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41(17):2613–2619PubMedCrossRef
22.
Zurück zum Zitat Kaur N, Gupta A, Sharma AK, Jain A (2018) Survivorship issues as determinants of quality of life after breast cancer treatment: report from a limited resource setting. Breast 41:120–126PubMedCrossRef Kaur N, Gupta A, Sharma AK, Jain A (2018) Survivorship issues as determinants of quality of life after breast cancer treatment: report from a limited resource setting. Breast 41:120–126PubMedCrossRef
23.
Zurück zum Zitat Soldera SV, Ennis M, Lohmann AE, Goodwin PJ (2018) Sexual health in long-term breast cancer survivors. Breast Cancer Res Treat 172:159–166PubMedCrossRef Soldera SV, Ennis M, Lohmann AE, Goodwin PJ (2018) Sexual health in long-term breast cancer survivors. Breast Cancer Res Treat 172:159–166PubMedCrossRef
24.
Zurück zum Zitat Son HM, Park EY, Kim EJ (2020) Cancer-related fatigue of breast cancer survivors: qualitative research. Asian Oncol Nurs 20(4):141–149CrossRef Son HM, Park EY, Kim EJ (2020) Cancer-related fatigue of breast cancer survivors: qualitative research. Asian Oncol Nurs 20(4):141–149CrossRef
25.
Zurück zum Zitat Tsai HY, Kuo RN, Chung KP (2017) Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. J Clin Oncol 47:909–918 Tsai HY, Kuo RN, Chung KP (2017) Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. J Clin Oncol 47:909–918
26.
Zurück zum Zitat Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22(11):2428–2435PubMedCrossRef Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22(11):2428–2435PubMedCrossRef
27.
Zurück zum Zitat Williams AF, Moffatt CJ, Franks PJ (2004) A phenomenological study of the lived experiences of people with lymphoedema. Int J Palliat Nurse 10:279–286CrossRef Williams AF, Moffatt CJ, Franks PJ (2004) A phenomenological study of the lived experiences of people with lymphoedema. Int J Palliat Nurse 10:279–286CrossRef
28.
Zurück zum Zitat Campagna M, Loscerbo R, Pilia I, Meloni F (2020) Return to work of breast cancer survivors: perspectives and challenges for occupational physicians. Cancers 12(2):355PubMedCentralCrossRef Campagna M, Loscerbo R, Pilia I, Meloni F (2020) Return to work of breast cancer survivors: perspectives and challenges for occupational physicians. Cancers 12(2):355PubMedCentralCrossRef
29.
Zurück zum Zitat Bijker R, Duijts SF, Smith SN, de Wildt-Liesveld R, Anema JR, Regeer BJ (2018) Functional impairments and work-related outcomes in breast cancer survivors: a systematic review. J Occup Rehabil 28(3):429–451PubMedCrossRef Bijker R, Duijts SF, Smith SN, de Wildt-Liesveld R, Anema JR, Regeer BJ (2018) Functional impairments and work-related outcomes in breast cancer survivors: a systematic review. J Occup Rehabil 28(3):429–451PubMedCrossRef
30.
Zurück zum Zitat Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology 23:361–374PubMedCrossRef Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology 23:361–374PubMedCrossRef
31.
Zurück zum Zitat Llewellyn A, Howard C, McCabe C (2019) An exploration of the experiences of women treated with radiotherapy for breast cancer: learning from recent and historical cohorts to identify enduring needs. Eur J Oncol Nurs 39:47–54PubMedCrossRef Llewellyn A, Howard C, McCabe C (2019) An exploration of the experiences of women treated with radiotherapy for breast cancer: learning from recent and historical cohorts to identify enduring needs. Eur J Oncol Nurs 39:47–54PubMedCrossRef
32.
Zurück zum Zitat Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW, Snowden JA, Coleman RE (2009) Follow-up care for cancer survivors: the views of clinicians. Br J Cancer 101(4):568–574PubMedPubMedCentralCrossRef Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW, Snowden JA, Coleman RE (2009) Follow-up care for cancer survivors: the views of clinicians. Br J Cancer 101(4):568–574PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Lovibond SH, Lovibond PF (1995) Manual for depression anxiety stress scales (DASS), 2nd edn. The Psychology Foundation of Australia, Sydney Lovibond SH, Lovibond PF (1995) Manual for depression anxiety stress scales (DASS), 2nd edn. The Psychology Foundation of Australia, Sydney
34.
Zurück zum Zitat Henry JD, Crawford JR (2005) The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44(2):227–239PubMedCrossRef Henry JD, Crawford JR (2005) The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44(2):227–239PubMedCrossRef
35.
Zurück zum Zitat Fox RS, Lillis TA, Gerhart J, Hoerger M, Duberstein P (2018) Multiple group confirmatory factor analysis of the DASS-21 depression and anxiety scales: how do they perform in a cancer sample? Psychol Rep 121(3):548–565PubMedCrossRef Fox RS, Lillis TA, Gerhart J, Hoerger M, Duberstein P (2018) Multiple group confirmatory factor analysis of the DASS-21 depression and anxiety scales: how do they perform in a cancer sample? Psychol Rep 121(3):548–565PubMedCrossRef
36.
Zurück zum Zitat Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251PubMedCrossRef Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251PubMedCrossRef
37.
Zurück zum Zitat Fardell JE, Jones G, Smith AB et al (2018) Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence. Psychooncology 27(2):492–499PubMedCrossRef Fardell JE, Jones G, Smith AB et al (2018) Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence. Psychooncology 27(2):492–499PubMedCrossRef
38.
Zurück zum Zitat Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13(1):1–8CrossRef Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13(1):1–8CrossRef
39.
Zurück zum Zitat Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349–357PubMedCrossRef Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349–357PubMedCrossRef
40.
Zurück zum Zitat McMullen M, Lau PK, Taylor S, McTigue J, Cook A, Bamblett M, …, Johnson CE (2018) Factors associated with psychological distress amongst outpatient chemotherapy patients: an analysis of depression, anxiety and stress using the DASS-21. Appl Nurs Res 40:45–50 McMullen M, Lau PK, Taylor S, McTigue J, Cook A, Bamblett M, …, Johnson CE (2018) Factors associated with psychological distress amongst outpatient chemotherapy patients: an analysis of depression, anxiety and stress using the DASS-21. Appl Nurs Res 40:45–50
41.
Zurück zum Zitat Skeath P, Berger A (2017) “Living in the moment” among cancer survivors who report life-transforming change. Ann Palliat Med 6(3):227–236PubMedCrossRef Skeath P, Berger A (2017) “Living in the moment” among cancer survivors who report life-transforming change. Ann Palliat Med 6(3):227–236PubMedCrossRef
42.
Zurück zum Zitat Bredemeier K, Berenbaum H, Spielberg JM (2012) Worry and perceived threat of proximal and distal undesirable outcomes. J Anxiety Disord 26:425–429PubMedCrossRef Bredemeier K, Berenbaum H, Spielberg JM (2012) Worry and perceived threat of proximal and distal undesirable outcomes. J Anxiety Disord 26:425–429PubMedCrossRef
43.
Zurück zum Zitat Strout TD, Hillen M, Gutheil C et al (2018) Tolerance of uncertainty: a systematic review of health and healthcare-related outcomes. Patient Educ Couns 101(9):1518–1537PubMedCrossRef Strout TD, Hillen M, Gutheil C et al (2018) Tolerance of uncertainty: a systematic review of health and healthcare-related outcomes. Patient Educ Couns 101(9):1518–1537PubMedCrossRef
44.
Zurück zum Zitat Treanor C, Donnelly M (2015) Late effects of cancer and cancer treatment-the perspective of the patient. Support Care Cancer 24(1):337–346PubMedCrossRef Treanor C, Donnelly M (2015) Late effects of cancer and cancer treatment-the perspective of the patient. Support Care Cancer 24(1):337–346PubMedCrossRef
46.
Zurück zum Zitat Paschali AA, Hadjulis M, Papadimitriou A, Karademas EC (2015) Patient and physician reports of the information provided about illness and treatment: what matters for patients’ adaptation to cancer during treatment? Psychooncology 24(8):901–909PubMedCrossRef Paschali AA, Hadjulis M, Papadimitriou A, Karademas EC (2015) Patient and physician reports of the information provided about illness and treatment: what matters for patients’ adaptation to cancer during treatment? Psychooncology 24(8):901–909PubMedCrossRef
47.
Zurück zum Zitat Ke Y, Ng T, Chan A (2018) Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review. Support Care Cancer 26(7):2125–2141PubMedCrossRef Ke Y, Ng T, Chan A (2018) Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review. Support Care Cancer 26(7):2125–2141PubMedCrossRef
48.
Zurück zum Zitat Hua A, Sesto ME, Zhang X, Wassenaar TR, Tevaarwerk AJ (2020) Impact of survivorship care plans and planning on breast, colon, and prostate cancer survivors in a community oncology practice. J Cancer Educ 35:249–255PubMedCrossRef Hua A, Sesto ME, Zhang X, Wassenaar TR, Tevaarwerk AJ (2020) Impact of survivorship care plans and planning on breast, colon, and prostate cancer survivors in a community oncology practice. J Cancer Educ 35:249–255PubMedCrossRef
50.
Zurück zum Zitat Brennan ME, Gormally JF, Butow P, Boyle M, Spillane AJ (2014) Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 111:1899–1908PubMedPubMedCentralCrossRef Brennan ME, Gormally JF, Butow P, Boyle M, Spillane AJ (2014) Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 111:1899–1908PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat McAndrew LM, Musumeci-Szabó TJ, Mora PA et al (2008) Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol 13(2):195–204PubMedCrossRef McAndrew LM, Musumeci-Szabó TJ, Mora PA et al (2008) Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol 13(2):195–204PubMedCrossRef
52.
Zurück zum Zitat Spronk I, Korevaar JC, Schellevis FG, Albreht T, Burgers JS (2017) Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines. BMJ Open 7:e015118PubMedPubMedCentralCrossRef Spronk I, Korevaar JC, Schellevis FG, Albreht T, Burgers JS (2017) Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines. BMJ Open 7:e015118PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat McCabe MS, Baker SK, Huffman C, Miller K (2011) Optimizing survivorship care: academic and community clinic models. Health Services for Cancer Survivors. Springer, New York, pp 223–238CrossRef McCabe MS, Baker SK, Huffman C, Miller K (2011) Optimizing survivorship care: academic and community clinic models. Health Services for Cancer Survivors. Springer, New York, pp 223–238CrossRef
54.
Zurück zum Zitat Lindell RB, Koh SJ, Alvarez JM, Koyama T, Esbenshade AJ, Simmons JH, Friedman DL (2015) Knowledge of diagnosis, treatment history, and risk of late effects among childhood cancer survivors and parents: the impact of a survivorship clinic. Pediatr Blood Cancer 62(8):1444–1451PubMedCrossRef Lindell RB, Koh SJ, Alvarez JM, Koyama T, Esbenshade AJ, Simmons JH, Friedman DL (2015) Knowledge of diagnosis, treatment history, and risk of late effects among childhood cancer survivors and parents: the impact of a survivorship clinic. Pediatr Blood Cancer 62(8):1444–1451PubMedCrossRef
55.
Zurück zum Zitat Gilbert SM, Dunn RL, Wittmann D et al (2015) Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic. Cancer 121(9):1484–1491PubMedCrossRef Gilbert SM, Dunn RL, Wittmann D et al (2015) Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic. Cancer 121(9):1484–1491PubMedCrossRef
Metadaten
Titel
The untold story of late effects: a qualitative analysis of breast cancer survivors’ emotional responses to late effects
verfasst von
Jodie Rosenberg
Phyllis N. Butow
Joanne M. Shaw
Publikationsdatum
10.07.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06402-7

Weitere Artikel der Ausgabe 1/2022

Supportive Care in Cancer 1/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.